1-(6-Methyl-4-oxo-1,4-dihydropyrimidin-2-yl)-3-(4-phenoxyphenyl)guanidine

Catalog No.: 
ACSPBV516
CAS No.: 
510738-21-3
Molecular Formula: 
C18H17N5O2
Molecular Weight: 
335.37
1-(6-Methyl-4-oxo-1,4-dihydropyrimidin-2-yl)-3-(4-phenoxyphenyl)guanidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$499.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(6-Methyl-4-oxo-1,4-dihydropyrimidin-2-yl)-3-(4-phenoxyphenyl)guanidine
IUPAC Name2-(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-1-(4-phenoxyphenyl)guanidine
MDL No.MFCD03615519
Molecular FormulaC18H17N5O2
Molecular Weight335.37
SMILESN=C(NC1=CC=C(OC2=CC=CC=C2)C=C1)NC3=NC(C=C(C)N3)=O
InChI KeyKJFCEDOEAVKEPY-UHFFFAOYSA-N
SynonymN-(6-Methyl-4-oxo-1,4-dihydropyrimidin-2-yl)-N'-(4-phenoxyphenyl)guanidine;1-(6-Methyl-4-oxo-1,4-dihydropyrimidin-2-yl)-3-(4-phenoxyphenyl)guanidine;Guanidine, N-(1,6-dihydro-4-methyl-6-oxo-2-pyrimidinyl)-N'-(4-phenoxyphenyl)-
CAS No.510738-21-3

Synthetic Route by SureRoute

1. ACSPBV516 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQBMC283 route compound structure diagram
    ACQBMC2833977-29-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSPBV516 route product structure diagram
    ACSPBV516510738-21-3
Inquiry

2. ACSPBV516 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMFGI745 route compound structure diagram
    ACMFGI745139-59-3In Stock
  4. Then
  5. ACSPBV516 route product structure diagram
    ACSPBV516510738-21-3
Inquiry

3. ACSPBV516 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSPBV516 route product structure diagram
    ACSPBV516510738-21-3
Inquiry

Comments (0)